menu
    • menu

    Company profile for Avalon GloboCare

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avalon GloboCare Corp. is a clinical-stage, leading CellTech bio-developer dedicated to Advancing and Empowering Innovative, Transformative Immune Effector Cell Therapy Exosome Technology Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients’ growth, development, as well as competitiveness in healthcare and CellTech industry markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avalon GloboCareUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4400 Route 9 South Suite 3100 Freehold, NJ 07728
    Telephone
    Telephone
    (1)732-780-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.avalon-globocare.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
    Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas

    06 Dec 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/scoop-avalon-mpm-back-new-cns-biotech-with-scientific-chops-from-astellas/

    Kyle LaHucik ENDPTS
    06 Dec 2022
    Share Share
    Avalon GloboCare Announces Collaboration with the University of
    Avalon GloboCare Announces Collaboration with the University of

    29 Mar 2021

    // YAHOO

    https://finance.yahoo.com/news/avalon-globocare-announces-collaboration-university-132500580.html

    YAHOO
    29 Mar 2021
    Share Share
    Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU)
    Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU)

    30 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/30/2151758/0/en/Avalon-GloboCare-and-University-of-Natural-Resources-and-Life-Sciences-BOKU-Expand-Partnership-and-Accelerate-Development-of-S-Layer-Based-Vaccines-and-Cellular-Therapeutics.html

    GLOBENEWSWIRE
    30 Dec 2020
    Share Share
    Avalon GloboCare Announces Successful Completion of Phase I Clinical Study
    Avalon GloboCare Announces Successful Completion of Phase I Clinical Study

    29 Jun 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/06/29/2054788/0/en/Avalon-GloboCare-Announces-Successful-Completion-of-Phase-I-Clinical-Study-of-CAR-T-Cell-Therapy-Candidate-AVA-001.html

    GLOBENEWSWIRE
    29 Jun 2020
    Share Share
    Avalon GloboCare to develop intranasal and oral Covid-19 vaccine
    Avalon GloboCare to develop intranasal and oral Covid-19 vaccine

    26 Jun 2020

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/avalon-covid19-vaccine/

    PHARMACEUTICAL-TECHNOLOGY
    26 Jun 2020
    Share Share
    Avalon GloboCare to develop intranasal and oral Covid-19 vaccine
    Avalon GloboCare to develop intranasal and oral Covid-19 vaccine

    25 Jun 2020

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/avalon-covid19-vaccine/

    PHARMACEUTICAL-TECHNOLOGY
    25 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search